IceCure Medical Ltd (ICCM)
1.13
0.02 (1.80%)
At close: Mar 31, 2025, 12:18 PM
IceCure Medical Ltd Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 3.29M | 3.23M | 3.08M | 4.14M | 4.08M | 1.66M | 1.07M | 689.38K | 625.49K | 762.87K | 1.07M | 354.63K |
| Cost of Revenue | 1.84M | 1.93M | 1.64M | 1.94M | 1.43M | 1.08M | 623.17K | 514.44K | 403.99K | 486.21K | 692.1K | 453.98K |
| Gross Profit | 1.45M | 1.3M | 1.45M | 2.19M | 2.66M | 576.41K | 448.73K | 174.93K | 221.49K | 276.66K | 376.48K | -99.35K |
| Operating Income | -15.7M | -15.58M | -16.74M | -9.72M | -4.36M | -4.61M | -3.17M | -2.66M | -3.1M | -3.53M | -4.1M | -3.75M |
| Interest Income | n/a | n/a | n/a | n/a | 4.04K | -178.76K | 531.04 | 2.01K | 3.9K | 8.71K | 12.58K | 28.14K |
| Pretax Income | -15.32M | -14.65M | -16.98M | -9.89M | -4.69M | -4.77M | -3.53M | -2.88M | -3.27M | -3.75M | -4.71M | -4.57M |
| Net Income | -15.32M | -14.65M | -17.22M | -10.07M | -4.78M | -4.76M | -3.53M | -2.88M | -3.27M | -3.75M | -4.71M | -4.57M |
| Selling & General & Admin | 10.05M | 8.6M | 9.06M | 6.04M | 2.87M | 2.34M | 1.68M | 1.34M | 1.66M | 2.82M | 3.47M | 2.81M |
| Research & Development | 7.1M | 8.27M | 9.12M | 5.88M | 4.08M | 2.85M | 1.94M | 1.5M | 1.66M | 980.87K | 1.01M | 846.52K |
| Other Expenses | n/a | n/a | n/a | n/a | 70.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 17.15M | 16.88M | 18.18M | 11.92M | 7.02M | 5.19M | 3.62M | 2.84M | 3.33M | 3.81M | 4.47M | 3.65M |
| Interest Expense | n/a | n/a | 239K | n/a | 31.72K | 22.81K | 63.46K | 58.12K | 154.94K | 198.53K | 639.97K | 465.47K |
| Selling & Marketing Expenses | 1.14M | 4.44M | 3.2M | 1.92M | 1.11M | 1.02M | 612.55K | 319.66K | 717K | 1.49M | 2.17M | 1.65M |
| Cost & Expenses | 18.99M | 18.8M | 19.82M | 13.86M | 8.45M | 6.27M | 4.24M | 3.35M | 3.73M | 4.29M | 5.16M | 4.11M |
| Income Tax | n/a | n/a | 239K | 171K | 86.77K | -13.57K | -1.13M | -640.93K | -458.76K | -614.09K | -1.8M | -2.38M |
| Shares Outstanding (Basic) | n/a | 45.64M | 37.02M | 28.55M | 17.13M | 13.62M | 11.67M | 6.26M | 5.3M | 3.27M | 1.28M | 593.95K |
| Shares Outstanding (Diluted) | n/a | 45.64M | 37.02M | 28.55M | 17.13M | 13.62M | 11.67M | 6.26M | 5.3M | 3.27M | 1.28M | 593.96K |
| EPS (Basic) | n/a | -0.32 | -0.47 | -0.35 | -0.28 | -0.35 | -0.3 | -0.46 | -0.62 | -1.15 | -3.69 | -7.7 |
| EPS (Diluted) | n/a | -0.32 | -0.47 | -0.35 | -0.28 | -0.35 | -0.3 | -0.46 | -0.62 | -1.15 | -3.69 | -7.7 |
| EBITDA | -15.36M | -15.25M | -16.49M | -9.6M | -4.08M | -4.6M | -3.42M | -2.75M | -3.03M | -3.69M | -3.98M | -3.95M |
| Depreciation & Amortization | 332K | 323K | 248K | 127K | 63K | 155.37K | 30.8K | 33.38K | 54.07K | 63.02K | 113K | 138.41K |